This model has served as a robust platform for discovering genetic and small-molecule modifiers of TDP-43 toxicity that have been validated in fly, mouse, human cells, and neuronal models of ALS/FTD41–47. Here, TARDBP is linked to amyotrophic lateral sclerosis.